Trent G. Kamke - Mar 2, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Mar 2, 2022
Transactions value $
-$275,357
Form type
4
Date filed
3/4/2022, 03:46 PM
Previous filing
Dec 27, 2021
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $55.9K +3.95K +34.43% $14.13* 15.4K Mar 2, 2022 Direct F1
transaction LMAT Common Stock Options Exercise $51.1K +1.63K +10.58% $31.30 17.1K Mar 2, 2022 Direct F1
transaction LMAT Common Stock Sale -$382K -7.93K -46.44% $48.22 9.14K Mar 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -3.95K -100% $0.00* 0 Mar 2, 2022 Common Stock 3.95K $14.13 Direct F3
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1.63K -47.93% $0.00 1.77K Mar 2, 2022 Common Stock 1.63K $31.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $48.00 to $48.65. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is fully vested and exercisable.
F4 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.